跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CEFALEXIN SANDOZ cefalexin (as monohydrate) 250mg/5mL powder for suspension bottle - TGA Drug Approval Details
Approvals
/
TGA
/
CEFALEXIN SANDOZ cefalexin (as monohydrate) 250mg/5mL powder for suspension bottle
Approved
STANDARD
CEFALEXIN SANDOZ cefalexin (as monohydrate) 250mg/5mL powder for suspension bottle
Sandoz Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
64c26f8fea6a11d1
Company
Sandoz Pty Ltd
Type
Standard
Approval Details
Approval Id
64c26f8fea6a11d1
Product Name
CEFALEXIN SANDOZ cefalexin (as monohydrate) 250mg/5mL powder for suspension bottle
Artg Id
78982
Artg Name
CEFALEXIN SANDOZ cefalexin (as monohydrate) 250mg/5mL powder for suspension bottle
Sponsor
Sandoz Pty Ltd
Company Detail Path
/organization/sandoz-pty-ltd
Artg Date
2002-03-11
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/10f02314c99840b6f4313a2ff13a9b70.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/b3dc18180add552a191f337c2e72e5a2.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
64c26f8fea6a11d1
Type
Standard
Back to TGA Approvals